As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives * Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice 54321 Explain the updated classification of diffuse gliomas. Explain the updated classification of diffuse gliomas. - 5 Explain the updated classification of diffuse gliomas. - 4 Explain the updated classification of diffuse gliomas. - 3 Explain the updated classification of diffuse gliomas. - 2 Explain the updated classification of diffuse gliomas. - 1 Discuss the frequency and prognostic implications of molecular profiles in gliomas. Discuss the frequency and prognostic implications of molecular profiles in gliomas. - 5 Discuss the frequency and prognostic implications of molecular profiles in gliomas. - 4 Discuss the frequency and prognostic implications of molecular profiles in gliomas. - 3 Discuss the frequency and prognostic implications of molecular profiles in gliomas. - 2 Discuss the frequency and prognostic implications of molecular profiles in gliomas. - 1 Assess the advances in treatment modalities and their relationship to molecular profiles. Assess the advances in treatment modalities and their relationship to molecular profiles. - 5 Assess the advances in treatment modalities and their relationship to molecular profiles. - 4 Assess the advances in treatment modalities and their relationship to molecular profiles. - 3 Assess the advances in treatment modalities and their relationship to molecular profiles. - 2 Assess the advances in treatment modalities and their relationship to molecular profiles. - 1 Rate the following * Scoring Key: 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor 54321 Course content. Course content. - 5 Course content. - 4 Course content. - 3 Course content. - 2 Course content. - 1 Yazmín Odia, M.D., M.S. Yazmín Odia, M.D., M.S. - 5 Yazmín Odia, M.D., M.S. - 4 Yazmín Odia, M.D., M.S. - 3 Yazmín Odia, M.D., M.S. - 2 Yazmín Odia, M.D., M.S. - 1 Was this course fair, balanced and without commercial bias? * Yes No If you checked "No,” please explain why: * How many patients will you see in your practice who will likely be impacted by what you learned at this activity? * 1-5 6-10 Over 10 Not applicable to my practice What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? * If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so. * Comments Please select one: * M.D., D.O. Ph.D. Psy.D. DPM PA-C ARNP R.N. Pharmacist Respiratory Therapist SW/MFT/MHC Other... Please select one: Other... Name Leave this field blank
